AVGO trades against a final fair-value range of $147.02-$261.25, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $147, high $261, with mid-point at $203.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$203
Margin of safety
-102.8%
Confidence
88/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$412.56Price
Low $147.02
Mid $203.48
High $261.25
AVGO trades against a final fair-value range of $147.02-$261.25, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
High switching costs in infrastructure
High switching costs in infrastructure software via VMware.
Intangible assets in custom silicon
Intangible assets in custom silicon design for hyperscalers.
Bull thesis
Value: Deeply overvalued. The implied 30%+ 10-year growth rate is mathematically improbable.
AVGO (AVGO)'s balance sheet section reports total assets, total liabilities, shareholders' equity, and the structure of debt versus cash so leverage and liquidity can be read directly.
Balance-sheet quality is tracked through net-debt position, interest-coverage trends, and changes in working capital. Material deterioration is flagged in the numbers-analysis subsection together with the income-statement read.
We report total debt and net debt (debt minus cash) on each balance-sheet snapshot. The trajectory across five years lets the reader judge whether debt is being reduced, held steady, or stepped up to fund operations.
Shareholders' equity is reported alongside book-value-per-share metrics where applicable. Buyback-driven equity declines are separated from operating-loss-driven declines so the reader can interpret the change correctly.
FAQ
AVGO — frequently asked questions
Based on our latest analysis, AVGO looks meaningfully overvalued. The current price is $413 versus a composite fair-value midpoint of $203 (range $147–$261), which implies roughly 50.7% downside to the midpoint.
Our composite fair-value range for AVGO is $147–$261, with a midpoint of $203. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for AVGO's archetype.
Our current rating for AVGO is Sell with a confidence score of 88/100. AVGO is rated Sell at $412.56 versus the reconciled fair value midpoint of $203.48, implying -50.68% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for AVGO are: Hyperscaler Silicon Independence; VMware Integration Failure; AI CapEx Digestion Cycle. The single biggest risk is Momentum: Dangerously extended. The market multiple is detached from fundamental DCF gravity.
Our current rating for AVGO is Sell, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($147–$261) versus the current price of $413.
AVGO is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for AVGO.
